SLK: A Potential Drug Target and Biomarker for Cancer (G9748)

Target Name: SLK

NCBI ID: G9748

Content of Review Report on SLK Target / Biomarker

SLK

SLK: A Potential Drug Target and Biomarker for Cancer

SLK (CTCL tumor antigen se20-9) is a protein that is expressed in various tissues, including the brain, lung, liver, and gastrointestinal tract. It is also a potential drug target and biomarker for various diseases, including cancer.

The protein encoded by the SLK gene is a member of the immunoglobulin superfamily and has a molecular weight of approximately 180 kDa. It consists of two heavy chains and two light chains that are held together by disulfide bonds. The heavy chains contain four constant (C) regions and one variable (V) region, while the light chains contain one variable (V) region and one constant (C) region.

SLK is highly expressed in various tissues and is expressed in the brain, lung, liver, and gastrointestinal tract, among others. It has been shown to be involved in various physiological processes, including cell signaling, inflammation, and immune responses.

SLK has also been shown to be a potential drug target and biomarker for various diseases, including cancer. For example, studies have shown that inhibiting SLK can lead to increased cell proliferation and survival in cancer cells. Additionally, SLK has been shown to be overexpressed in various types of cancer, including breast, lung, and ovarian cancer.

In addition to its potential as a drug target, SLK has also been shown to be a potential biomarker for cancer. For example, studies have shown that the expression of SLK is associated with the development and progression of various types of cancer. Additionally, SLK has been shown to be a useful marker for evaluating the effectiveness of cancer treatments.

Overall, SLK is a protein that has important roles in various physiological processes and has been shown to be involved in the development and progression of cancer. As a potential drug target and biomarker, SLK is a promising target for future research and clinical trials.

Protein Name: STE20 Like Kinase

Functions: Mediates apoptosis and actin stress fiber dissolution

The "SLK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLK comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets